144 related articles for article (PubMed ID: 26808584)
21. Post-translational modifications of Trypanosoma cruzi histone H4.
da Cunha JP; Nakayasu ES; de Almeida IC; Schenkman S
Mol Biochem Parasitol; 2006 Dec; 150(2):268-77. PubMed ID: 17010453
[TBL] [Abstract][Full Text] [Related]
22. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.
Noberini R; Longuespée R; Richichi C; Pruneri G; Kriegsmann M; Pelicci G; Bonaldi T
Clin Epigenetics; 2017; 9():69. PubMed ID: 28702092
[TBL] [Abstract][Full Text] [Related]
23. Imaging mass spectrometry for lipidomics.
Goto-Inoue N; Hayasaka T; Zaima N; Setou M
Biochim Biophys Acta; 2011 Nov; 1811(11):961-9. PubMed ID: 21440085
[TBL] [Abstract][Full Text] [Related]
24. HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging.
Zane L; Chapus F; Pegoraro G; Misteli T
Mol Biol Cell; 2017 Aug; 28(17):2290-2302. PubMed ID: 28615324
[TBL] [Abstract][Full Text] [Related]
25. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
26. Posttranslational modifications of human histone H3: an update.
Xu YM; Du JY; Lau AT
Proteomics; 2014 Sep; 14(17-18):2047-60. PubMed ID: 25044606
[TBL] [Abstract][Full Text] [Related]
27. Extensive histone post-translational modification in honey bees.
Dickman MJ; Kucharski R; Maleszka R; Hurd PJ
Insect Biochem Mol Biol; 2013 Feb; 43(2):125-37. PubMed ID: 23174121
[TBL] [Abstract][Full Text] [Related]
28. LC-MALDI-TOF ISD MS analysis is an effective, simple and rapid method of investigation for histones characterization: Application to EBV lymphoblastoid cell lines.
De Benedittis S; Gaspari M; Magariello A; Spadafora P; Citrigno L; Romeo N; Qualtieri A
J Mass Spectrom; 2021 Feb; 56(5):e4712. PubMed ID: 33851762
[TBL] [Abstract][Full Text] [Related]
29. Mass spectrometric analysis of histone posttranslational modifications.
Burlingame AL; Zhang X; Chalkley RJ
Methods; 2005 Aug; 36(4):383-94. PubMed ID: 16112065
[TBL] [Abstract][Full Text] [Related]
30. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry.
Hardouin J
Mass Spectrom Rev; 2007; 26(5):672-82. PubMed ID: 17492750
[TBL] [Abstract][Full Text] [Related]
31. MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue.
Hanrieder J; Wicher G; Bergquist J; Andersson M; Fex-Svenningsen A
Anal Bioanal Chem; 2011 Jul; 401(1):135-47. PubMed ID: 21553124
[TBL] [Abstract][Full Text] [Related]
32. Histone H4 acetylation dynamics determined by stable isotope labeling with amino acids in cell culture and mass spectrometry.
Su X; Zhang L; Lucas DM; Davis ME; Knapp AR; Green-Church KB; Marcucci G; Parthun MR; Byrd JC; Freitas MA
Anal Biochem; 2007 Apr; 363(1):22-34. PubMed ID: 17286952
[TBL] [Abstract][Full Text] [Related]
33. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
34. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
[TBL] [Abstract][Full Text] [Related]
35. MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery.
Reyzer ML; Caprioli RM
J Proteome Res; 2005; 4(4):1138-42. PubMed ID: 16083264
[TBL] [Abstract][Full Text] [Related]
36. Characterization of antimicrobial histone sequences and posttranslational modifications by mass spectrometry.
Ouvry-Patat SA; Schey KL
J Mass Spectrom; 2007 May; 42(5):664-74. PubMed ID: 17405180
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Posttranslational Modifications on Histone Variants.
Saavedra F; Marty-Lombardi S; Loyola A
Methods Mol Biol; 2018; 1832():21-49. PubMed ID: 30073520
[TBL] [Abstract][Full Text] [Related]
38. Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS): peering into the cup of Jamshid.
Valentino LA
Haemophilia; 2014 May; 20(3):304-5. PubMed ID: 24731128
[TBL] [Abstract][Full Text] [Related]
39. Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications.
Noberini R; Restellini C; Savoia EO; Bonaldi T
Methods; 2020 Dec; 184():19-28. PubMed ID: 31605746
[TBL] [Abstract][Full Text] [Related]
40. Middle-down hybrid chromatography/tandem mass spectrometry workflow for characterization of combinatorial post-translational modifications in histones.
Sidoli S; Schwämmle V; Ruminowicz C; Hansen TA; Wu X; Helin K; Jensen ON
Proteomics; 2014 Oct; 14(19):2200-11. PubMed ID: 25073878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
